I don't think either is out of the question, but I would say pharmaceutical might be their focus based on their specialization of "advanced derivatives". However that could also translate into any products which need consistent and specific extracted ingredients. They might just be able to do it all, given the facilities to do so.
Honestly I wouldn't want to guess which comes first. I'm just happy to hold my core shares without a thought of selling them anytime soon. Will I trade a few? Sure will. Will I look back and wish I hadn't. Probably.
News 
Market Data 
Discover 
